Arcutis Biotherapeutics Cash from Financing (Quarterly) Trends

Arcutis Biotherapeutics Inc (ARQT)

9.93 -0.54 (-5.16%) USD | NASDAQ | Nov 14, 16:00

9.93 0.00 (0.00%) Pre-Market: 08:48

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
September 30, 2024	0.394M
June 30, 2024	1.455M
March 31, 2024	161.76M
December 31, 2023	99.29M
September 30, 2023	0.867M
June 30, 2023	1.067M
March 31, 2023	0.10M
December 31, 2022	0.962M
September 30, 2022	284.99M
June 30, 2022	1.131M
March 31, 2022	14.72M
December 31, 2021	72.88M

Date	Value
September 30, 2021	0.063M
June 30, 2021	1.188M
March 31, 2021	207.82M
December 31, 2020	129.38M
September 30, 2020	-0.437M
June 30, 2020	0.309M
March 31, 2020	168.89M
December 31, 2019	92.96M
September 30, 2019	-0.02M
June 30, 2019	0.168M
March 31, 2019	0.00

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-0.437M

Minimum

Sep 2020

284.99M

Maximum

Sep 2022

61.99M

Average

1.322M

Median

Cash from Financing (Quarterly) Benchmarks

Mirum Pharmaceuticals Inc	7.291M
Biogen Inc	-6.60M
Vertex Pharmaceuticals Inc	-387.50M
NovaBay Pharmaceuticals Inc	2.089M
Palatin Technologies Inc	5.991M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-34.69M
Cash from Investing (Quarterly)	84.78M
Free Cash Flow	-167.80M
Free Cash Flow Per Share (Quarterly)	-0.2802
Free Cash Flow to Equity (Quarterly)	-35.63M
Free Cash Flow to Firm (Quarterly)	-28.18M
Free Cash Flow Yield	-14.84%